ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Vineet Laboratories Ltd reported revenue from operations of ₹14.2 Cr (-18.4% YoY) and net profit of ₹0.1 Cr (-75.0% YoY) for Q2 FY27.
Vineet Laboratories filed its FY 2025-26 Annual Report, which marks its turnaround and recapitalisation year. The AGM is scheduled for 30 November 2026.
Vineet Laboratories has circulated notice of its 10th AGM, scheduled for 30 November 2026 via video conferencing. The filing attaches the FY 2025-26 annual report.
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Vineet Laboratories appointed SVRL & Co. as statutory auditor after NSVR & Associates resigned. Internal, cost and secretarial auditor changes were also approved.
Vineet Laboratories will hold a board meeting on 4 November 2026 to approve the 10th AGM notice and FY2025-26 Directors' Report. The filing is an advance notice; the agenda is proposed only.
Vineet Laboratories Ltd reported revenue from operations of ₹10.4 Cr (+40.5% YoY) and net profit of ₹1.5 Cr for Q1 FY27.
Vineet Laboratories Limited has scheduled a board meeting on October 26, 2026, to consider and approve standalone financial results for the quarter ended June 30, 2026.
Vineet Laboratories Ltd has filed its quarterly shareholding pattern as per Regulation 31(1)(b) of SEBI (LODR) Regulations for the quarter ended September 30, 2026.
Mr. Vennapusa Premanand Reddy has resigned as a Director of Vineet Laboratories Limited, effective October 14, 2026.
Vineet Laboratories Limited announced the resignation of M/s. NSVR & Associates LLP as its statutory auditor, effective September 29, 2026. The company will appoint a successor.
Vineet Laboratories received an extension from the Registrar of Companies, Hyderabad, to hold its 10th Annual General Meeting by 30th November 2026.
Vineet Laboratories Ltd reported revenue from operations of ₹18.9 Cr (+34.0% YoY) and net profit of ₹0.7 Cr for Q4 FY26.
Vineet Laboratories Limited scheduled a board meeting for August 25, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026.
Vineet Laboratories filed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming the utilization of Rights Issue proceeds as per the offer document.
Vineet Laboratories Limited submitted a certificate declaring non-applicability of Corporate Governance provisions for the quarter ended June 30, 2026, due to meeting regulatory threshold exemptions.
Vineet Laboratories Limited has appointed Mr. Rajesh Kumar Kathulla as an Additional Director (Executive Category), effective June 11, 2026, subject to shareholder approval.
Vineet Laboratories scheduled a board meeting on July 15, 2026. The board will consider audited standalone financial results for FY26.
Vineet Laboratories deferred approval of its FY26 financial results as the Audit Committee had not yet recommended them. The trading window remains closed until results are declared.
Mr. Ramesh Kumar Bandari resigned as Company Secretary and Compliance Officer effective May 29, 2026. This administrative change follows his personal decision to step down.
Vineet Laboratories scheduled a board meeting for May 30, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-announcement.